SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000885590-12-000048
Filing Date
2012-07-03
Accepted
2012-07-03 12:45:05
Documents
1
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3349
  Complete submission text file 0000885590-12-000048.txt   4911
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 WINDSOR STREET WESTMOUNT A8 H3Y 2L8
Business Address
Segal Lloyd Mitchell (Reporting) CIK: 0001477123 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 12943203